sacituzumab govitecan
gilead sciences
['bcsm', 'breast', 'tropics02']
second oral #breastcancer abstract at #asco22: presented by super first data from the #tropics02 trial showing the efficacy and safety of #sacituzumabgovitecan in heavily pretreated patients with #hr+/#her2- advanced disease #bcsm 
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Prior @myESMO fellow. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.